Document is current
Any future updates will be listed below
-
Authors
Feinkohl, Insa https://orcid.org/0000-0002-0307-1862
Borchers, Friedrich
Burkhardt, Sarah
Krampe, Henning
Kraft, Antje
Speidel, Saya
Kant, Ilse M. J.
van Montfort, Simone J. T.
Aarts, Ellen
Kruppa, Jochen
Slooter, Arjen
Winterer, Georg
Pischon, Tobias
Spies, Claudia
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct02265263 at ClinicalTrials.govDocuments that mention this clinical trial
Stability of neuropsychological test performance in older adults serving as normative controls for a study on postoperative cognitive dysfunction
https://doi.org/10.1186/s13104-020-4919-3
Preoperative thalamus volume is not associated with preoperative cognitive impairment (preCI) or postoperative cognitive dysfunction (POCD)
https://doi.org/10.1038/s41598-023-38673-x
Preoperative Comparison of Three Anticholinergic Drug Scales in Older Adult Patients and Development of Postoperative Delirium: A Prospective Observational Study
https://doi.org/10.1007/s40266-021-00839-5
Association between genetic variants of the cholinergic system and postoperative delirium and cognitive dysfunction in elderly patients
https://doi.org/10.1186/s12920-021-01071-1
-
Funding
Funding for this research was provided by:
Seventh Framework Programme (HEALTH‐F2‐2014‐602461)
- License Information
-
More Information
Article History
Received: 1 August 2019
Accepted: 24 January 2020
First Online: 4 February 2020
Ethics approval and consent to participate
: Participants gave written informed consent to participate in the study. The study protocol was approved by the local ethics committees (Ethikkommission Charité Universitätsmedizin Berlin, Reference No. EA2/092/14 and Medisch Ethische Toetsingscommissie, Universitair Medisch Centrum Utrecht, Reference No. 14-469) and was conducted in accordance with the Declaration of Helsinki. The BioCog study was registered on ClinicalTrials.gov Identifier: NCT02265263.
: Not applicable.
: GW is coordinator of the BioCog consortium and is chief executive of the company Pharmaimage Biomarker Solutions GmbH []. Among other academic and private partners, the company is a partner of the BioCog study. CS and TP are project leaders in BioCog. CS, TP, IF, FB, SB, HK, AK, SS, IK, SM, EA, JK, and AJ declare that they have no competing of interest.
